For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Blog
How State Directed Payments turned Medicaid into an interstate transfer scheme
Medicaid’s financing rules have long allowed states to expand spending while shifting much of the cost to federal taxpayers. One of the most important…
Search Posts
The Wall Street Journal
The White House Prepared for a Pandemic
New York Gov. Andrew Cuomo launched the Democrats’ broadside against the Trump administration’s Covid-19 response. “Our current federal government is dysfunctional and incompetent,” he told…
Letters
CEI Joins Coalition Letter Opposing Most Favored Nation Drug Pricing Proposal
On behalf of the undersigned federal and state-based organizations, we write to express our grave concerns with the “most favored nation” (MFN) executive order to impose foreign…
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
Inside Sources
Government Contact Tracing Won’t Help Get Americans Back to Work, but Innovation Will
Contact tracing identifies people who have an infectious disease (cases) and people they came in contact with (contacts) who may have become infected.
News Release
Price Controls for Medicines Risk Harming Innovation When Breakthrough Drugs or Vaccines May Mean Life or Death
President Trump is expected to issue an executive order today directing his administration to take a series of actions related to pharmaceuticals and the price…
Study
#NeverNeeded Price Gouging Laws Would Harm COVID-19 Response
Price gouging becomes a hot topic during every crisis. It has become especially topical during the COVID-19 crisis. Almost overnight, the need exploded for goods…
